Immunotech Biopharm Ltd historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-02-10 | 2.310 | 2.600 | 2.310 | 2.590 | 2.381 | 277,000 |
| 2025-02-07 | 2.460 | 2.460 | 2.270 | 2.300 | 2.115 | 532,000 |
| 2025-02-06 | 2.460 | 2.630 | 2.420 | 2.450 | 2.253 | 287,000 |
| 2025-02-05 | 2.540 | 2.550 | 2.350 | 2.370 | 2.179 | 356,000 |
| 2025-02-04 | 2.740 | 2.770 | 2.500 | 2.540 | 2.335 | 555,000 |
| 2025-02-03 | 2.730 | 2.790 | 2.690 | 2.720 | 2.501 | 40,000 |
| 2025-01-28 | 2.700 | 2.750 | 2.570 | 2.740 | 2.519 | 26,000 |
| 2025-01-27 | 2.790 | 2.790 | 2.600 | 2.790 | 2.565 | 199,000 |
| 2025-01-24 | 2.980 | 2.980 | 2.660 | 2.780 | 2.556 | 144,000 |
| 2025-01-23 | 2.540 | 2.920 | 2.520 | 2.760 | 2.538 | 1,460,000 |
| 2025-01-22 | 2.390 | 2.410 | 2.320 | 2.410 | 2.216 | 281,000 |
| 2025-01-21 | 2.420 | 2.490 | 2.390 | 2.390 | 2.197 | 106,000 |
| 2025-01-20 | 2.580 | 2.580 | 2.420 | 2.420 | 2.225 | 84,000 |
| 2025-01-17 | 2.310 | 2.600 | 2.310 | 2.580 | 2.372 | 403,000 |
| 2025-01-16 | 2.360 | 2.380 | 2.330 | 2.330 | 2.142 | 12,000 |
| 2025-01-15 | 2.250 | 2.360 | 2.240 | 2.360 | 2.170 | 330,000 |
| 2025-01-14 | 2.260 | 2.350 | 2.230 | 2.350 | 2.161 | 174,000 |
| 2025-01-13 | 2.490 | 2.520 | 2.250 | 2.250 | 2.069 | 77,000 |
| 2025-01-10 | 2.330 | 2.430 | 2.330 | 2.380 | 2.188 | 60,000 |
| 2025-01-09 | 2.320 | 2.350 | 2.280 | 2.330 | 2.142 | 50,000 |
| 2025-01-08 | 2.470 | 2.530 | 2.350 | 2.350 | 2.161 | 237,000 |
| 2025-01-07 | 2.450 | 3.000 | 2.370 | 2.450 | 2.253 | 412,000 |
| 2025-01-06 | 2.320 | 2.490 | 2.320 | 2.400 | 2.207 | 77,000 |
| 2025-01-03 | 2.230 | 2.340 | 2.200 | 2.320 | 2.133 | 351,000 |
| 2025-01-02 | 2.260 | 2.350 | 2.220 | 2.220 | 2.041 | 166,000 |
| 2024-12-31 | 2.370 | 2.440 | 2.280 | 2.300 | 2.115 | 180,000 |
| 2024-12-30 | 2.320 | 2.460 | 2.280 | 2.330 | 2.142 | 199,000 |
| 2024-12-27 | 2.400 | 2.400 | 2.200 | 2.250 | 2.069 | 130,000 |
| 2024-12-24 | 2.400 | 2.400 | 2.400 | 2.400 | 2.207 | 0 |
| 2024-12-23 | 2.540 | 2.560 | 2.370 | 2.400 | 2.207 | 77,000 |
| 2024-12-20 | 2.560 | 2.560 | 2.320 | 2.340 | 2.151 | 170,000 |
| 2024-12-19 | 2.180 | 2.520 | 2.080 | 2.380 | 2.188 | 965,000 |
| 2024-12-18 | 2.340 | 2.340 | 2.000 | 2.280 | 2.096 | 661,000 |
| 2024-12-17 | 2.490 | 2.500 | 2.320 | 2.390 | 2.197 | 751,000 |
| 2024-12-16 | 2.750 | 2.750 | 2.490 | 2.550 | 2.345 | 354,000 |
| 2024-12-13 | 2.980 | 2.980 | 2.550 | 2.750 | 2.528 | 1,981,000 |
| 2024-12-12 | 2.830 | 2.990 | 2.780 | 2.980 | 2.740 | 297,000 |
| 2024-12-11 | 3.050 | 3.050 | 2.800 | 2.930 | 2.694 | 357,000 |
| 2024-12-10 | 2.950 | 3.160 | 2.940 | 3.040 | 2.795 | 1,031,000 |
| 2024-12-09 | 2.540 | 3.090 | 2.540 | 2.950 | 2.712 | 2,179,000 |
| 2024-12-06 | 2.210 | 2.510 | 2.210 | 2.510 | 2.308 | 588,000 |
| 2024-12-05 | 2.150 | 2.190 | 2.100 | 2.180 | 2.004 | 86,000 |
| 2024-12-04 | 2.120 | 2.150 | 2.090 | 2.150 | 1.977 | 168,000 |
| 2024-12-03 | 2.100 | 2.180 | 2.100 | 2.150 | 1.977 | 198,000 |
| 2024-12-02 | 2.240 | 2.240 | 2.150 | 2.180 | 2.004 | 178,000 |
| 2024-11-29 | 2.240 | 2.250 | 2.100 | 2.160 | 1.986 | 252,000 |
| 2024-11-28 | 2.050 | 2.300 | 1.870 | 2.160 | 1.986 | 243,000 |
| 2024-11-27 | 1.990 | 1.990 | 1.860 | 1.860 | 1.710 | 151,000 |
| 2024-11-26 | 1.950 | 1.950 | 1.890 | 1.890 | 1.738 | 136,000 |
| 2024-11-25 | 1.770 | 1.970 | 1.770 | 1.930 | 1.775 | 378,000 |
| 2024-11-22 | 1.750 | 1.860 | 1.700 | 1.770 | 1.627 | 294,000 |
| 2024-11-21 | 1.800 | 1.890 | 1.700 | 1.890 | 1.738 | 148,000 |
| 2024-11-20 | 1.980 | 1.980 | 1.800 | 1.800 | 1.655 | 361,000 |
| 2024-11-19 | 1.740 | 1.800 | 1.730 | 1.800 | 1.655 | 390,000 |
| 2024-11-18 | 1.780 | 1.780 | 1.700 | 1.730 | 1.591 | 102,000 |
| 2024-11-15 | 1.710 | 1.960 | 1.700 | 1.870 | 1.719 | 791,000 |
| 2024-11-14 | 1.520 | 1.600 | 1.520 | 1.600 | 1.471 | 81,000 |
| 2024-11-13 | 1.630 | 1.720 | 1.500 | 1.520 | 1.398 | 1,233,000 |
| 2024-11-12 | 1.750 | 1.750 | 1.600 | 1.620 | 1.490 | 1,217,330 |
| 2024-11-11 | 1.750 | 1.870 | 1.610 | 1.750 | 1.609 | 1,166,000 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (HKD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.